公开(公告)号：US12123998B1

公开(公告)日：2024-10-22

申请号：US18411805

申请日：2024-01-12

Applicant: SHANDONG UNIVERSITY

Inventor： Yang Yang ,  Shucai Li ,  Heng Zhang ,  Yuzhen Zhu ,  Huaifeng Sun

IPC: G01V3/08

CPC classification number: G01V3/083 ,  G01V2003/084 ,  G01V2003/085

Abstract: A system and method for controlled-source electromagnetic exploration is based on staggered frequency excitation of crossed sources. Different high-order pseudo-random signals are transmitted using two sources, respectively, each set of high-order pseudo-random signals may contain sufficient frequencies within a same complete frequency range, exploration frequencies of the two sets of signals are completely staggered, simultaneous transmission by the two field sources is implemented, and different polarization modes do not affect each other and are separated from each other. Moreover, different measuring line directions at a receiving terminal can be observed simultaneously, and each measuring point has two polarization directions, thus greatly improving the exploration efficiency and the data volume.

公开(公告)号：US20200031844A1

公开(公告)日：2020-01-30

申请号：US15735135

申请日：2016-07-12

Applicant: SHANDONG UNIVERSITY

Inventor： Xinyong Liu ,  Heng Zhang ,  Peng Zhan ,  Zhongxia Zhou ,  Dongwei Kang

IPC: C07D495/04 ,  A61P31/18

Abstract: The invention relates the tetrahydrothiopyranopyrimidine derivatives, the preparation, and the use thereof. The invention contained tetrahydrothiopyranopyrimidine derivatives, and pharmaceutical acceptable salt and prodrug with the formula I or II. Also described here are preparation of tetrahydrothiopyranopyrimidine derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for HIV.

公开(公告)号：US10590145B2

公开(公告)日：2020-03-17

申请号：US15735135

申请日：2016-07-12

Applicant: SHANDONG UNIVERSITY

Inventor： Xinyong Liu ,  Heng Zhang ,  Peng Zhan ,  Zhongxia Zhou ,  Dongwei Kang

IPC: C07D495/06 ,  A61K31/519 ,  C07D495/04 ,  A61P31/18

Abstract: The invention relates the tetrahydrothiopyranopyrimidine derivatives, the preparation, and the use thereof. The invention contained tetrahydrothiopyranopyrimidine derivatives, and pharmaceutical acceptable salt and prodrug with the formula I or II. Also described here are preparation of tetrahydrothiopyranopyrimidine derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for HIV.